Personal profile
In Korean
민상현 교수(첨단기술융합대학 혁신신약학과)
Education
o (1997) B..S, Chungbuk National University
o (1999) M.S., Chungbuk National University
o (2009) Ph.D., KAIST
o (1999) M.S., Chungbuk National University
o (2009) Ph.D., KAIST
Professional Experience
o (2024~Present) Assistant Professor, Kyungpook National University, Daegu, Korea
o (2012~2024) Principal Researcher, K-MEDI hub, Daegu, Korea
o (2009~2012) Research Fellow, Harvard Medical School (BIDMC), MA, USA
o (2006~2009) Researcher-Postdoctoral Researcher, KAIST, Daejeon, Korea
o (1999~2006) Researcher, KRIBB, Daejeon, Korea
o (2012~2024) Principal Researcher, K-MEDI hub, Daegu, Korea
o (2009~2012) Research Fellow, Harvard Medical School (BIDMC), MA, USA
o (2006~2009) Researcher-Postdoctoral Researcher, KAIST, Daejeon, Korea
o (1999~2006) Researcher, KRIBB, Daejeon, Korea
Research Interests
Focusing on synthetic drug development, we try to discover and develop small-molecule drugs based on the target-oriented drug discovery for several diseases including cancers, osteoporosis, obesity and diabetes. Also, we are interested in phenotype based drug screening using patient-originated iPS (induced pluripotent stem cells) anc cancer stem cells (CSC) as a trial of drug reposition.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Sang-Hyun Min is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Enhancing CYP3A4 Inhibition Prediction Using a Hybrid GNN–ML Model with Data Augmentation
Woo, S., Jeon, J. H., Han, S., Lee, C. & Min, S. H., Feb 2026, In: Pharmaceuticals. 19, 2, 258.Research output: Contribution to journal › Article › peer-review
Open Access -
Pyrrolopyrimidines: A promising scaffold for the development of novel cathepsin K inhibitors
Lee, J., Jung, G. N., Jung, K. J., Kim, J. W., Ma, M. J., Lee, Y., Yu, J. H., Min, S. H. & Lee, J. H., 15 Jan 2026, In: European Journal of Medicinal Chemistry. 302, 118323.Research output: Contribution to journal › Article › peer-review
-
Anti-proteolytic regulation of KRAS by USP9X/NDRG3 in KRAS-driven cancer development
Koo, H., Park, K. C., Sohn, H. A., Kang, M., Kim, D. J., Park, Z. Y., Park, S., Min, S. H., Park, S. H., You, Y. M., Han, Y., Kim, B. K., Lee, C. H., Kim, Y. S., Chung, S. J., Yeom, Y. I. & Lee, D. C., Dec 2025, In: Nature Communications. 16, 1, 628.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Targeting RARγ Decreases Immunosuppressive Macrophage Polarization and Reduces Tumor Growth
Park, J., Oh, J., Min, S. H., Yu, J. H., Bae, J. S. & Jeon, H. J., Aug 2025, In: Molecules. 30, 15, 3099.Research output: Contribution to journal › Article › peer-review
Open Access -
Therapeutic Effects of TN13 Peptide on Acute Respiratory Distress Syndrome and Sepsis Models In Vivo
Byun, J. E., Lee, J. W., Choi, E. J., Lee, J., Yun, S. H., Park, C. H., Kim, H., Kim, M. S., Yoon, S. R., Kim, T. D., Noh, J. Y., Min, S. H., Seong, H. A., Ahn, K. S., Choi, I. & Jung, H., Mar 2025, In: Journal of Clinical Medicine. 14, 6, 1804.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations